Existing methods for evaluating the potential gonadotoxicity of environmental agents and pharmaceutical compounds rely heavily on animal studies. The current gold standard in vivo functional assays in animals are limited in their human predictive capacity. In addition, existing human twodimensional in vitro models of testicular toxicity do not accurately reflect the in vivo situation. A more reliable testicular in vitro model system is needed to better assess the gonadotoxic potential of drugs prior to progression into clinical trials. The overall goal of this study was to develop a three-dimensional (3D) in vitro human testis organoid culture system for use as both a predictive first tier drug-screening tool and as a model of human testicular function. Multicellular human testicular organoids composed of Spermatogonial Stem Cells, Sertoli, Leydig and peritubular cells were created and evaluated over time for morphology, viability, androgen production and ability to support germ cell differentiation. Enzyme-linked immunosorbent assay measurements confirmed that the organoids produced testosterone continuously with and without hCG stimulation. Upregulation of postmeiotic genes including PRM1 and Acrosin, detected by quantitative-PCR, digital PCR and Immunofluorescence, indicated the transition of a small percentage of diploid to haploid germ cells. As a novel screening tool for reproductive toxicity, 3D organoids were exposed to four chemotherapeutic drugs, and they responded in a dose-dependent manner and maintained IC50 values significantly higher than 2D cultures. This 3D human testis organoid system has the potential to be used as a novel testicular toxicity-screening tool and in vitro model for human spermatogenesis.
Introduction
The mammalian testis maintains an elaborate communication network between several cell types and subpopulations that cooperatively drives differentiation of male germ cells to haploid gametes, and the production of androgens via the process of steroidogenesis [1] [2] [3] [4] . This dual functionality reflects activities of two distinct testicular regions, the seminiferous tubules, and interstitial tissue of the testis [5] . Primitive spermatogonia confined to the basement membrane of the seminiferous epithelium develop in close contact with Sertoli cells [6] . As spermatogonia progress from the basement membrane into the intermediate and adluminal compartments, they differentiate into spermatocytes and spermatids, eventually giving rise to mature sperm. Steroidogenesis is the biological process of steroid hormone synthesis from cholesterol precursors [3] . Leydig cells are located in the testicular interstitium and secrete testosterone initiating the masculinization of the fetal gonad and maintaining postpubertal spermatogenesis/spermatogenesis [7] . The overall efficiency and success of spermatogenesis relies heavily on the presence of the Sertoli cell-spermatogonial stem cell (SSC) niche [8] . This relationship between the developing germ cells and the surrounding testicular environment allows for the correct spatial arrangement of cells and enables them to receive and interpret the various signals and factors necessary for SSC self-renewal and germ cell differentiation.
The isolation, characterization, and culture of testicular cells from rodents has been well studied [9] . Among the most successful culture systems using isolated cells were two-dimensional (2D) Sertoli-germ cell cocultures incorporating extracellular matrix (ECM) components [10] [11] [12] . Complete spermatogenesis in vitro has been reported in the mouse using decapsulated mouse testis in a soft-agar organ-culture method [13, 14] . The construction of human 3D microtissue organoids for use in toxicity and functional assays could bridge the gap between currently accepted in vitro cell culture models and in vivo functional analyses [15] [16] [17] . A scalable, high-throughput 3D human testicular cell culture system that mimics the essential functionality of the native tissue would be a first step toward more predictive drug screening and reduce dependence on animal testing. We have established methods for isolation and long-term culture of human SSC from cryopreserved testicular tissue [18, 19] . This approach allowed us to combine Leydig, Sertoli [20] [21] [22] [23] [24] , and SSC into a single multicellular testis organoid. The objective of this study was to develop a three-dimensional (3D) human testis organoid culture system for use as both a predictive first tier drug-screening tool and as a model of human testicular function in vitro.
Materials and methods

Human testes tissue
Adult testicular tissues (whole organ) from three brain dead patients (ages 56-61) were procured through the National Disease Research Interchange (NDRI). Testicular tissue was used for human testis ECM extraction (see next section) or cut into small segments to be used for cryopreservation and immunohistochemical testing. For cryopreservation, tissue fragments (∼2-5 mm) were frozen in 1× minimum essential medium containing 8% DMSO, 20% fetal bovine serum (FBS) slowly overnight using a Mr. Frosty container (Thermofisher Scientific) inside a -80
• C freezer. Cryotubes were moved to liquid nitrogen (-196 • C) for long-term storage. For all of the cell isolations, cryopreserved tissue was used. Tissue pieces used for immunohistochemical staining were fixed in 4% paraformaldehyde and paraffin embedded. Morphology of testes, stained by hematoxylin and eosin (H&E), showed normal spermatogenesis in all three patient samples used in this study. All human materials in this study were used under-regulation and approval of institutional review board of Wake Forest School of Medicine.
Decellularization of human testis tissues and extracellular matrix extraction
To include all important factors that may support testis function in vivo, the human testis ECM [25] [26] [27] was extracted and added to the culture medium. Fresh testis tissues obtained from the NDRI were first prerinsed in cold Dulbecco phosphate-buffered saline (PBS). The tunica albuginea was left intact for this procedure and the entire testis organ was cut into 2 cm × 2 cm slices then sectioned into roughly 2 mm slices. The material was then moved to 500 mL containers containing ultrapure water and shaken on a rotary shaker at 4
• C for 3 days at 200 rpm. During this time, ultrapure water was changed three times per day. After 72 h, the water was replaced with 2% Triton-X-100 for approximately 4 days. These solutions were changed twice daily. This solution was then replaced with a solution of 2% Triton-X-100 containing 0.1% NH 4 OH and shaken at 200 rpm for 24 h. This solution was then removed, and the tissues were washed to remove remaining Triton-X-100 detergent. Decellularized ECMs were frozen at -80 • C and lyophilized for 48 h. The lyophilized tissues were ground using a freezer mill, and 400 mg ECM was subsequently mixed with 40 mg Pepsin (Porcine gastric mucosa, 3400 units, Fisher Scientific, Fair Lawn, NJ). To this mixture, 0.1 N hydrochloric acid was added and incubated for 48 h at room temperature. The suspension was neutralized to pH 7.2 using NaOH and filter sterilized through a 0.2-μm filter and stored at -80 • C until further use.
Formation and culture of three-dimensional testis organoids SSC, Leydig cells, and Sertoli cells were isolated from cryopreserved fragments of normal adult human testicular tissue. After isolation, Sertoli and Leydig cells were immortalized using a lentivirus expressing hTERT (pBABE puro hTERT) [28] 
Immunofluorescence for germ cell differentiation markers
Samples were deparaffinized, then permeabilized with 0.2% Triton X-100 (Sigma) and put through microwave antigen retrieval (AR6 buffer Perkin Elmer). Spheroid sections were blocked for 10 min with serum-free protein block (Dako), and then stained in antibody diluent (Dako) overnight at 4˚C with primary antibody (Rabbit Antihuman Acrosin, HPA048687 diluted 1:3000 or rabbit Antihuman PRM1, HPA055150 diluted 1:125 both from Sigma-Aldrich). Following several washes with Tris-buffered saline (TBST), sections were then incubated with goat antirabbit, HRP-labeled antibody (NEF812001EA, Perkin Elmer) for 1 h at room temperature. Following three washes with TBST, sections were treated with tyramide signal amplification (TSA) Plus Fluorescence working solution and selected fluorophore (Perkin Elmer) for 10 min at room temperature (Fluorescein for PRM1 and Cyanine 5.5 for Acrosin). Slides were then washed three times and stained with DAPI (Perkin Elmer) for 5 min. Slides were then washed again with TBST. Prolong gold mounting medium (life technologies) was used for coverslip application. Gold Seal coverslips were used (Electron Microscopy Sciences). All slides were imaged with FV1200 Laser Scanning Confocal Microscope.
Testosterone production
Androgen production in primary cultures of immortalized Leydig cells and 3D organoids was measured using a testosterone highsensitivity ELISA kit (ENZO NY) according to the manufacturer's instructions. The minimum detectible limit was 3.9 pg/mL. A total of 20 organoids (or equal number of Leydig cells primary culture) per time point were used in this assessment, with half stimulated with 2 nM human Chorionic Gonadotropin (hCG) for 3 h. Following incubation, cell culture supernatant was collected from stimulated and nonstimulated organoids and concentrated 4× using an Eppendorf Vacufuge. All samples were assayed in duplicate. A standard curve was generated and used to determine testosterone concentrations.
Testosterone levels were determined via optical density at 405-nm wavelength absorbance.
Digital PCR for germ cells markers
To estimate the percentage of undiferrentiated and differentiated germ cells at day 23th of culture, we used a Digital PCR system (Quant Studio, Life Technologies) and Taqman assays labeled with VIC (for POLR2A as housekeeping gene) and FAM for target genes (Supplementary Table 1 ). As each mammalian cell has a range of 10-30 pg of total RNA, for each assay we used the cDNA made from 50 ng of total RNA of day 23th testis oragnoids distributed in 20 000 wells of Digital PCR chip. Therfore, each well of Digiatl PCR chip should represent zero (empty) or one cell equivalent. Reactions were performed using QuantStudio 3D Digital PCR Master Mix and run on an QuantStudio 3D Digital system (Life Technologies). For each PCR chip, cDNA was added to supplemented master mix with two Taqman 
Drug toxicity test
For toxicity testing, cisplatin and etoposide were purchased from Santa Cruz Biotechnology (California, USA) and stock solutions of 5 and 25 mM were made in 0.9% NaCl and DMSO, respectively. Doxorubicin was purchased from Sigma-Aldrich, (St. Louis, USA), and a stock solution was produced in diH 2 O at a concentration of 10 mM. Busulfan (24 mM) was purchased from Otsuka Pharmaceutical (Tokyo, Japan) and was diluted into media immediately prior to use. The undifferentiated (just after formation, 2 days in culture) and differentiated (23 days in culture) organoids as well as 2D cultured cells (using the same cells types and at the same cell ratios and density of 3D organoids) were treated for 48 h in six different concentrations of each drug (0.01, 0.1, 1, 10, 100, and 1000 μM) in vitro. After 48 h, CellTiter-Glo Luminescent Cell Viability assays were performed (Promega) on all conditions. Briefly, culture plates were removed from the incubator and equilibrated to room temperature for 30 min. To each well of the 96-well culture plate, 100 μL of CellTiter-Glo reagent was added at a 1:1 ratio, and plates were moved to an orbital shaker for 5 min to induce cell lysis. Plates were incubated at room temperature for 10 min to stabilize luminescent signal and read on a Veritas luminometer. Integration times of 1 s were used for all samples. All conditions were performed in triplicate and media-only control wells were read and subsequently used for background subtraction. IC 50 values were determined using GraphPad Prism 6 calculated via 4-parameter fit with a 95% confidence interval. All experimental conditions were repeated at least three times.
Cryopreservation and thawing of testicular organoids Standard cryopreservation
Following 48-72 h of hanging drop culture and subsequent transfer to 96-well Corning Costar Ultra-low Attachment Multiwell Ubottom plates, organoids were harvested, pooled, and cryopreserved in 8% DMSO and 20% FBS in 1× MEM by using a Mr. Frosty freezing container. Organoids were thawed after 7 days storage at -196
• C using a stepwise dilution of cryoprotectant media into a normal organoid culture media containing 30% FBS. Organoids were allowed to recover in this media for 1 h prior to transfer to 96-well Ultra-low Attachment Multiwell U-bottom plates and resuming of normal culture conditions.
Vitrification
Following 48-72 h of hanging drop culture and subsequent transfer to 96-well Corning Costar Ultra-low Attachment Multiwell U-bottom plates, organoids were harvested, pooled, and vitrified using a vitrification freeze kit for human embryos (Vit Kit-Freeze, Irvine Scientific, USA) according to manufacturer's recommendations. Organoids were thawed after 7 days storage at -196 • C using a vitrification thaw kit for human embryos following manufacturer's recommendations (Vit Kit-thaw, Irvine Scientific, USA). Organoids were then moved to 96-well Ultra-low Attachment Multiwell U-bottom plates and normal culture conditions were resumed.
Statistical analyses
Statistical analysis of all quantitative results is presented as mean +/-standard deviation (SD). Statistical significance was determined using Student t-test, with p values < 0.05 considered statistically significant. Statistics were determined using GraphPad Prism 6 software.
Results
Formation and characterization of multicellular human testicular organoids
Before proceeding with the formation of the testis organoids, the integrity of the component cell types was assessed. As shown in Figure 1C ), and they produced testosterone with and without hCG stimulation ( Figure 1D ).
As an initial baseline evaluation of internal morphology, organoids were harvested, paraffin embedded, and sectioned for H&E staining ( Figure 1E ). It can be seen that a compact, tight organoid was generated with no detectable necrosis in the center. It has been reported by several investigators that when multicellular 3D organoids are formed, they show a degree of self-organization not found in 2D cultures. To see if this were also the case with testis organoids, each component cell culture (SSC, Sertoli, Leydig) was stained with one of three available cell surface-labeling fluorescent dyes (Vybrant, Invitrogen). Labeled cells were then combined into an organoid and evaluated for organizational changes over time ( Figure 1F ). Interestingly, we observed a propensity of our cells to self-organize during extended culture as indicated by the association of germ cells within the center of each organoid with somatic cells targeting to the periphery of the structure.
Long-term morphological characteristics and viability of multicellular human testicular organoids in vitro
Organoids were harvested after 2, 9, 16, and 23 days of culture and examined for morphological characteristics, viability, and internal organization. At day 2 organoids appeared uniform and tightly packed with cells (Figure 2A: I) . By day 9 and 16, more ECM was visible within the structure ( Figure 2AII and III) and by day 23 (Figure 2A: IV), organoids were found to have increased in size from approximately 250 μm to ∼400 μm, most probably due to ECM production as not many cells were in proliferation stage ( Figure 2C , right). The cells also changed morphology somewhat to larger clearlike cells, although there were no obvious signs of necrosis. Viability at each time point was assessed using confocal microscopy after live/dead staining and ATP quantitation. No significant cell death was observed during the 23-day culture period for any organoid (Figure 2BI-IV) . ATP assays (CellTiter-Glo Promega) showed that the organoids (n = 6) maintained greater than 85% viability throughout the entire culture period ( Figure 2D ).
Transcriptional changes of functional and stage-specific genes during extended culture
Somatic cell functional markers and spermatogenesis-specific gene expression was evaluated in human testicular organoid cultures over time as shown in Figure 3A . Of these markers, we were not able to detect significant increase in expression level of SYCP3, a meiotic germ cell marker, during the culture period. The spermatogonial marker DAZL, which is expressed in differentiating spermatogonia (nuclear) through meiosis (cytoplasmic) and in round spermatids, was significantly upregulated over time with a fold change of 35.28 at day 23. Significant increases in the postmeiotic germ cell markers PRM1 (18-fold increase) and Acrosin (9-fold increase) occurred (Figure 3A Figure 3A ). All quantitative RT-PCR data were normalized to the housekeeping gene POLR2A as an internal control.
Expression of postmeiotic germ cell markers during extended culture
Detection of postmeiotic germ cell markers at the protien level was confirmed via immunostaining of differentiated testicular organoids following culture for 23 days in differentiation media. Cells positive for PRM1( Figure 3B ) and Acrosin ( Figure 3C ) could be localized in differentiated organoids. Human adult testis tissue was stained as a positive control ( Supplementary Figure 2A and B) .
Multicellular human testicular organoids can be stimulated to produce androgens during extended culture
To test the ability of 3D human testicular organoids to produce androgens and respond to androgen stimulation in vitro, culture supernatant was measured for total testosterone (n = 10) concentration per 100 000 cells before and after stimulation with 2 ng/mL hCG for 3 h. At day 2, nonstimulated testosterone concentrations were 97.168 ± 17.471 pg/mL; after hCG stimulation, concentrations were 151.325 ± 11.592 pg/mL ( Figure 3D ). Stimulation at day 2 resulted in testosterone levels significantly higher than nonstimulated cells (p = 0.00039 Figure 3D ).
Quantitation of cell types in day 23 differentiated organoids
To gain information on the percentage of cells present at the end of 3D culture (day 23), a digital PCR system was used. We found that 52% of cells in differentiated organiods express ZBTB16 (PLZF) representing undifferentiated spematogonia ( 
Evaluation of human testicular organoids as a potential reproductive toxicity model
To evaluate the use of human testicular organoids as a novel screening tool for reproductive toxicity, 3D organoids were exposed to four clinically relevant antimitotic chemotherapeutic drugs: busulfan, cisplatin, doxorubicin, and etoposide. To obtain IC50 values, undifferentiated (2 days in culture) and differentiated (23 days in culture) organoids were exposed to increasing concentrations of drugs for 48 h. Hematoxylin and eosin staining as well as live/dead viability assays were performed on organoids following drug treatment ( Figure 5A and B). Drug-treated organoids were harvested and further evaluated for toxicity by measuring ATP production (CellTiter-Glo, Promega, WI). Resulting viability was then used to establish IC 50 values for organoid cultures ( Figure 5C : I and II). Three-dimensional organoids under all drug treatment conditions, either undifferentiated or differentiated organoids, exhibited a dose-dependent decrease in viability and maintained IC 50 values significantly higher than corresponding 2D cultures ( Figure 5C : III). Caspase 3/7 activity and TUNEL assay (Supplementary Figure 1) following 48-h exposure to four drugs showed significant increase in organoid cells apoptosis.
Cryopreservation and viability assessment of human testicular organoids
To investigate the feasibility of cryopreserving organoids for longterm storage and distribution, we evaluated two distinct cryopreservation protocols immediately after thawing and subsequent 2-week postthaw recovery in culture. First, we cryopreserved organoids using our standard SSC freezing protocol of MEM supplemented with 20% FBS and 8% DMSO (slow freezing). After 7 days of liquid nitrogen storage, organoids were thawed and their morphology and viability were determined via phase contrast microscopy and fluorescent live/dead staining followed by macro confocal microscopy. These assays were performed immediately after thawing and again at 7 and 14 days postthawing. When compared to control samples obtained at day 2 of normal culture ( Figure 6A ), the cryopreserved and thawed organoids appeared to be stressed, as indicated by the small compact cellular phenotype of the cells within the organoid. However, no significant cell death was observed within the structure. By day 7 postthaw, the cells within the organoid had visibly recovered and displayed a normal phenotype. No significant cell death was observed within organoids cryopreserved in this manner and organoids maintained greater than 90% viability for the duration of the 14-day culture period ( Figure 6A ). We also evaluated vitrification as a method of cryopreservation, following a protocol routinely used to preserve human embryos for in vitro fertilization [30, 31] . Organoids were vitrified, kept frozen for 7 days, and thawed using standard thawing methods for vitrified human embryos [30, 31] . They were then cultured at 34
• C and 5% CO 2 for 14 days.
Compared to organoids cryopreserved slowly in DMSO, vitrified organoids appeared less stressed and analysis revealed that vitrified organoids maintained greater than 95% viability after thawing and for the subsequent 14 days of additional culture ( Figure 6B ).
Discussion
This study was designed to address the current limitations of models of testicular toxicity, by developing a multicellular human 3D testicular organoid platform capable of supporting spermatogenesis and responsive to androgen stimulation. Such a platform, if viable, could then be tailored to address general and specific toxicity assessments on testicular cells, particularly SSC and differentiating daughter germ cells.
To reflect the complex signaling environment of the native tissue, we isolated and characterized all three of the primary cell types of the testis from human tissue fragments (SSC, Sertoli, and Leydig cells) and successfully integrated them into 3-D multicellular organoids. Our hanging drop approach allowed significant control of size, and cellular composition, while allowing easy mechanical manipulation for subsequent assays and experimental procedures. Our culture system was initially optimized for germ cell survival and proliferation with a media formulation used for the expansion of human SSC in vitro [29, 32] . To more closely mirror the human in vivo testicular microenvironment, we included isolated human testis ECM in our organoid culture media. Testis ECM contains growth factors and other proteins that facilitate spermatogenesis and steroidogenesis in vivo [26, 33] .
After initial establishment of basic culture design parameters including organoid size (250-350 μM), media combinations (optimized for germ cell proliferation), and cell ratios (80% SSC, 10% Sertoli, 10% Leydig), we evaluated long-term viability and morphological changes over time since spermatogenesis takes more than 30 days in mouse, and approximately 60 days in humans [6] . To expand the usefulness of this system we modified our culture media to assist in promoting spermatogonial differentiation within our organoid cultures. We added several factors that promote spermatogenic differentiation in vitro [34, 35] , including follicle-stimulating hormone, stem cell factor, and retinoic acid. For the entire 23-day culture period, no significant decreases in viability were observed, as determined by ATP production over time. The diameter of the organoids increased over time, most probably a result of native ECM proteins being excreted, rather than an increase in overall cell number (based on H&E staining). Although core necrosis due to anoxia has been reported in other spheroid cultures [36] , we did not observe necrosis in the center of any testicular organoids even at diameters up to 500-600 μM.
To evaluate androgen production from Leydig cells, with or without hCG (LH analog) stimulation, organoids were incubated with hCG for 3 h [22] and levels of testosterone were measured. Following a statistically significant increase in testosterone level after hCG stimulation of 3D organoids at day 2 of culture, subsequent stimulation of the same organoids did not result in further significant responses. Although this transient steroidogenic desensitization has been previously reported [37, 38] , it remains to be determined whether this observation is due to metabolic changes within the Leydig cells over time or if it is a result of stimulating the same organoids several times over an extended culture period. However, at all-time points, a consistent testosterone production that did not appear to be stimulation-dependent was maintained.
Due to the multicellular nature of the 3D organoid cultures, we sought to evaluate cell-specific gene expression over time using spermatogenesis stage-specific and somatic cell functional markers. We compared changes in gene expression at the beginning and end of the 23-day culture period to determine (1) the presence of active Leydig and Sertoli cells for the entire culture period, (2) whether Sertoli and Leydig cell functional markers change during the culture period, and (3) the extent of spermatogenesis that has occurred. UCHL1 and PLZF are characteristic undifferentiated spermatogonial markers, and expression levels of these markers remained unchanged during the culture period. This could indicate that the SSC pool in this 3D structure was able to maintain undifferentiated spermatogonia for the entire culture period. Alternatively, a proportion of the SSCs Confocal live/dead images of human testicular organoids cryopreserved by vitrification method. I. Fresh organoid 2 days in culture, as a positive control, was compared to vitrified freeze/thawed organoids immediately after thawing (II), and following an additional 7 days (III) and 14 days (IV) recovery in culture. These images were compared to a cold-methanol-treated organoid as a negative control (V). Vitrified organoids showed greater than 90% viability following thawing and subsequent culture (scale bar, 100 μm).
were able to undergo spermatogenic differentiation and were replaced by stem cell renewal divisions. A third possibility is that only early stage differentiated SSC, possibly already present within our 2D SSC cultures used for creating 3D organoids entered into postmeiotic phase leaving the true SSCs unchanged. We are currently investigating these possibilities.
Previous studies in rats showed that somatic cell functionality increased in Sertoli cell-germ cell cocultures, along with improved germ cell support and viability [39] . We utilized four somatic cell functional markers, 3β-HSD, CYP11a1 (Leydig cells), CYP19a1, and FSHr (Sertoli cells), to evaluate our organoid cultures over time. Normal testicular development is under direct androgen and gonadotropin signaling control, with the modulatory effect of these signals being directed through local control mechanisms. Among these, aromatase (CYP19A1) catalyzes the irreversible aromatization of androgens into estrogens. Leydig cells were initially believed to be the source of estrogen production in humans. However, several studies have since determined that in addition to Leydig cells, Sertoli and germ cells of varying stages of differentiation have the capacity to produce estrogens, although the direct mechanisms and role of estrogens in spermatogenesis remains to be elucidated [40] . Folliclestimulating hormone is strongly implicated in control of maturation as well as apoptosis of male germ cells. Its receptor, FSHr, has been reported to be localized not only on Sertoli cells, but also on spermatogonia up to the round spermatid stage [41, 42] . Both cholesterol side chain cleavage enzyme (CYP11A1) and 3β-HSD catalyze the first two steps of steroid synthesis from cholesterol precursors and are strongly expressed in mature human Leydig cells [43] . Gene expression of all four of these markers was significantly upregulated after 3 weeks in culture. These results indicate that testicular cells within our 3D organoid cultures are able to both synthesize steroids (confirmed via ELISA measurement of testosterone) and respond to hCG stimulation. Since differentiation of SSC is a key aspect of normal spermatogenesis, we further utilized four spermatogenesisspecific markers to measure the extent of germ cell differentiation within the organoids. Of these, DAZL (differentiating spermatogonia), SYCP3 (meiosis), PRM1 (postmeiotic), and ACR (elongated spermatids) were evaluated. Interestingly, we were not able to detect significant changes in SYCP3 expression during the culture period; however, DAZL, PRM1, and ACR transcripts were all significantly increased at 23 days. This result indicated a potential premeiotic bottleneck, which has been observed in previous studies involving in vitro spermatogenesis [44, 45] . In addition to transcript level, immunostaining of differentiated organoids confirmed the presence of cells expressing PRM1 and Acrosin proteins located in the nucleus and membrane, respectively. Taken together, these data indicate that the 3D human testicular organoid system has the capacity to support in vitro differentiation of diploid to haploid germ cells. This opens the door to further in vitro study of human spermatogenesis using this system. For instance, once fully optimized, it would provide a method for identifying the function of putative "true" stem cell populations fractioned on the basis of a number of different parameters [46] .
As a means to evaluate the potential of this model system for toxicity screening, we exposed organoids to four potential gonadotoxic chemotherapeutic drugs [47] : busulfan, cisplatin, doxorubicin, and etoposide. These are all antimitotic drugs that utilize differing mechanisms of action. Cisplatin, doxorubicin, and etoposide mainly act on proliferating cells, whereas busulfan has been shown to act specifically on nonproliferating or slowly proliferating cell types. Three-dimensional organoids were in two main groups, untreated and treated with drugs. Dose-response curves were generated by determining ATP levels at increasing concentrations of drug and revealed significant increases in IC 50 levels for all tested compounds. The results indicated that differentiated and undifferentiated testis organoids display a more drug-resistant phenotype than equivalent cell mixtures cultured in 2D systems. This could be due to altered drug uptake kinetics, and germ cell protection provided by the compact structure of the organoid. Our observations and initial optimization experiments determined that testicular cells cultured in standard 2D tissue culture plates tend to maintain a high proliferation rate that is not observed within 3D organoids, likely due to the 3D architecture of the organoid and a reduced ability of the cells to expand two dimensionally.
Many research groups have worked toward optimizing effective cryopreservation methods for 3D organoid cultures of various cell types including liver, heart, and brain. To date, most of these methods result in an unacceptable loss of cell viability and functionality after thawing [48] . However, an effective means of cryopreservation for 3D organoids will likely be necessary for transport and large-scale implementation of 3D cell culture models for routine drug screening. Our attempts at 3D organoid cryopreservation yielded very promising results. Over 90% of cells in cryopreserved 3D cultures retained viability after thawing and maintained viability for an additional 14 days in culture. We used two different methods of cryopreservation, assuming that vitrification would be more effective, since it is routinely used for long-term cold storage of human embryos. After thawing, vitrified organoids were indeed morphologically and viably indistinguishable from noncryopreserved controls. Organoids cryopreserved using standard human SSC freezing media also could be thawed and returned to normal culture without any appreciable loss in viability, although they took longer to regain normal cellular morphology. The prospect of being able to freeze-thaw 3D testicular organoids significantly increases their potential relevance as an accessible in vitro model.
In conclusion, our multicellular 3D testis organoid model reflects a physiologically relevant stucture because it includes multiple testicular cell types in a 3D environment that allows cell-cell contacts, cell polarization, native ECM production, cell-specific gene expression, androgen production, and long-term viability. Importantly, it mimics in vivo spermatogenesis by supporting the differentiation of SSC to postmeiotic germ cells, albeit at a low frequency of approximately 0.2% (Figure 4) . Once fully optimized with respect to spermatogenesis, such a testicular organoid could provide an invaluable model for studying basic germ cell biology. Importantly, it provides an initial first-tier drug-screening tool, bridging current in vitro methods and in vivo animal studies. Since these organoids are generated in 96-or 384-well formats, they are amenable to high-throughput screening protocols. Such screening of human organoids could significantly reduce the time required to evaluate potential drugs, and reduce the number of false-positive or false-negative results compared to those obtained from 2D cultures and animal studies. Finally, such screening human organoids would require many fewer experimental animals for testing.
Supplementary data
Supplementary data are available at BIOLRE online. Supplementary Figure 1. (A) Activation of caspase 3/7 in untreated and treated 3D testicular organoids following acute drug exposure. Luminescence produced by caspase 3/7 activity was measured following 48-h incubation and cell viability (% control) was compared to nontreated controls incubated for the same exposure time (n = 3). Data presented as mean ± SD. Significance: * p < 0.05; * * p < 0.01. (B) TUNEL staining of testicular organoids following acute drug exposure. Scale bar = 100 μm. Supplementary Figure 2 . Immunofluorescence staining of postmeiotic markers on human adult testis sections as positive controls. (A) PRM1: blue is DAPI and green is PRM1. (B) Acrosin: blue is DAPI and red is Acrosin. Scale bar = 5μm.
Supplementary Table 1 . Summary of Taqman Gene Expression Assays used for transcriptome analysis.
Supplementary Table 2 . Summary of antibodies used for Immunostaining
